Scoop has an Ethical Paywall
Work smarter with a Pro licence Learn More

Video | Business Headlines | Internet | Science | Scientific Ethics | Technology | Search

 

Solbec Announces Grant Of Australian Patent

SOLBEC ANNOUNCES GRANT OF AUSTRALIAN PATENT

Summary:
· Solbec advises the granting of Australian patent, number 779512, entitled “Medicinal compositions and their method of preparation”.


Perth, Australia. 14 June 2005. Solbec Pharmaceuticals (ASX: SBP) advises that the Australian patent, number 779512, entitled “Medicinal compositions and their method of preparation” has been granted. This provides additional protection to the Company’s lead compound Coramsine™. The term of the patent runs until April 2020.

The “Medicinal compositions” patent covers aspects of the manufacturing, purification process and formulation of the active pharmaceutical ingredients of Coramsine™. It is the second Coramsine™ related patent application to be granted. International cases of the application are ongoing.

Coramsine™ is now covered by seven families of patents / patent applications that are expected to provide protection until 2023. They extend to clinical application, extraction and purification, the cell receptor involved in Coramsine™ selectivity, Coramsine’s™ effect on Interleukin-6 production, and Coramsine™ combination therapy.

Background Information

Solbec Pharmaceuticals Ltd identifies naturally-occurring compounds with potential in the development of better therapies for debilitating conditions and life-threatening diseases. The company is currently progressing its key project, Coramsine™, through Phase I/IIA clinical trials for the treatment of advanced solid tumours, and as a topical treatment for psoriasis. Solbec's two proprietary ingredients in Coramsine™ were isolated from the fruit of a plant known as the Devil’s Apple (Solanum linnaeanum). They show activity against some cancers and cause potentially therapeutic changes to the immune system. In addition to human health, Coramsine™ has potential application in the areas of animal health and diagnostics. Solbec’s business strategy is to partner or out-license Coramsine™ for the final stages of pre-commercial development and marketing.

www.solbec.com.au

Advertisement - scroll to continue reading

Are you getting our free newsletter?

Subscribe to Scoop’s 'The Catch Up' our free weekly newsletter sent to your inbox every Monday with stories from across our network.

© Scoop Media

Advertisement - scroll to continue reading
 
 
 
Business Headlines | Sci-Tech Headlines

 
 
 
 
 
 
 
 
 
 
 
 
 

Join Our Free Newsletter

Subscribe to Scoop’s 'The Catch Up' our free weekly newsletter sent to your inbox every Monday with stories from across our network.